EHS
EHS

New patent for Sunovion Pharms drug APTIOM – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Sunovion Pharms drug APTIOM


Annual Drug Patent Expirations for APTIOM

Aptiom is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug and one Paragraph IV challenge.

APTIOM drug price trends.

Drug patent litigation for APTIOM.

This drug has eigthy-nine patent family members in twenty-seven countries.

The generic ingredient in APTIOM is eslicarbazepine acetate. One supplier is listed for this compound. Additional details are available on the eslicarbazepine acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Sunovion Pharms drug APTIOM



Source link

EHS
Back to top button